I-Corps: Blockchain-Enabled Patient Centric Consent To Improve Access To Care

这个I-Corps项目的更广泛的影响/商业潜力是开发一个软件系统，该系统将允许患者使用分布式账本技术有效地获得医疗第二意见。所提出的解决方案与现有的解决方案有着根本的不同。最近的研究确定了市场障碍，包括漫长的等待时间和不明确的成本。当前的第二意见解决方案没有解决互操作性和信息筒仓问题，并且它们保留了收集患者信息的负担。患者尽最大努力提供记录，但不幸的是，他们提供的信息很多时候是不充分的，并且不特定于他们的访问，偶尔需要重复成像/测试/研究。所提出的解决方案节省了医生的时间，并解决了非技术患者的当前障碍，因为它简化、组织并有效地将这些信息呈现给医生，以便清楚地了解患者的状况。目前的医疗第二意见市场规模估计到2025年将达到71亿美元。这个I-Corps项目基于分布式账本技术的开发，该技术解决了患者面临的挑战，使他们的完整医疗图表可用于传播。目前，信息驻留具有不同的模式和透明度要求，并且分散在各个医生和机构中。拟议的技术使用分布式账本内置的基础设施，在法律允许的情况下，每次访问和使用患者数据时，都可以支持无缝的患者控制、通知甚至补偿。将数据附加到分布式账本基础设施可以实现自动跟踪机制，该机制可以随时支持数据的透明使用。该技术通过确保医生可以访问收集的患者记录，帮助减少患者的等待时间。此外，通过避免已经进行的不必要的检查，帮助患者进行第二意见的成本估算。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impact/commercial potential of this I-Corps project is the development of a software system that will allow patients’ efficient accessibility to medical second opinions using distributed ledger technology. The proposed solution is fundamentally different than existing solutions. Recent studies identified barriers to the market including long waiting times and unclear costs. The current second opinion solutions do not address the interoperability and information silo problem, and they keep the burden of collecting information on patients. Patients provide records to the best of their ability, but unfortunately many times the information they provide is insufficient, and not specific to their visit, which occasionally requires repeat imaging/testing/studies. The proposed solution saves physicians time and addresses current barriers of non-technical patients as it simplifies, organizes, and efficiently presents this information to a physician for a clear picture of the patient's condition. Current medical second opinion market size is estimated to be $7.1 Billion by 2025.This I-Corps project is based on the development of a distributed ledger technology that solves the challenge faced by patients to have their complete medical charts available for dissemination. Currently, the information resides is with different modalities and transparency requirements and is scattered among various physicians and institutions. The proposed technology uses the distributed ledger built-in infrastructure to support seamless patient control, notification, and even compensation, when permitted by law, every time their data is accessed and used. Having the data attached with a distributed ledger infrastructure enables an automated tracing mechanism that may support a transparent use of data any time. The technology helps minimize the patients waiting time by ensuring the accessibility of the collected patient records to physicians. In addition, it helps the patient with the cost estimation of the second opinion by preventing unnecessary tests already done.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.